Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae

被引:22
|
作者
Hayakawa, Kayoko [1 ]
Nakano, Ryuichi [2 ]
Hase, Ryota [3 ]
Shimatani, Michitsugu [4 ]
Kato, Hideaki [5 ]
Hasumi, Jumpei [6 ]
Doi, Asako [7 ]
Sekiya, Noritaka [8 ]
Nei, Takahito [9 ]
Okinaka, Keiji [10 ]
Kasahara, Kei [11 ]
Kurai, Hanako [12 ]
Nagashima, Maki [1 ]
Miyoshi-Akiyama, Tohru [13 ]
Kakuta, Risako [2 ]
Yano, Hisakazu [2 ]
Ohmagari, Norio [1 ]
机构
[1] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan
[2] Nara Med Univ, Dept Microbiol & Infect Dis, Nara, Japan
[3] Japanese Red Cross Narita Hosp, Dept Infect Dis, Chiba, Japan
[4] Hamamatsu Med Ctr, Dept Infect Dis & Infect Control, Shizuoka, Japan
[5] Yokohama City Univ Med, Infect Prevent & Control Dept, Yokohama, Kanagawa, Japan
[6] Saku Med Ctr, Dept Pediat, Nagano, Japan
[7] Kobe City Med Ctr Gen Hosp, Div Infect Dis, Kobe, Hyogo, Japan
[8] Komagome Hosp, Dept Infect Prevent & Control, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[9] Nippon Med Coll Hosp, Dept Infect Prevent & Control, Tokyo, Japan
[10] Natl Canc Ctr Hosp East, Div Gen Internal Med, Chiba, Japan
[11] Nara Med Univ, Ctr Infect Dis, Nara, Japan
[12] Shizuoka Canc Ctr, Div Infect Dis, Shizuoka, Japan
[13] Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Tokyo, Japan
关键词
ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; INACTIVATION METHOD; MULTIPLEX PCR; PREVALENCE; OUTCOMES; HEALTH; JAPAN;
D O I
10.1093/jac/dkz501
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are classified as carbapenemase-producing Enterobacteriaceae (CPE) and non-CPE; the majority of CPE in Japan produce IMP carbapenemase. Objectives: We evaluated the clinico-epidemiological and microbiological information and effects of IMP-type carbapenemase production in CRE. Methods: Patients with isolations of CRE (MICs of meropenem >= 2mg/L, imipenem >= 2mg/L or cefmetazole >= 64mg/L) from August 2016 to March 2018 were included. Microbiological analyses and WGS were conducted and clinical parameters were compared between groups. Independent predictors for the isolation of CPE from patients were identified by logistic regression. For comparing clinical outcomes, a stabilized inverse probability weighting method was used to conduct propensity score-adjusted analysis. Results: Ninety isolates (27 CPE and 63 non-CPE) were collected from 88 patients (25 CPE and 63 non-CPE). All CPE tested positive for IMP carbapenemase. Antibiotic resistance (and the presence of resistance genes) was more frequent in the CPE group than in the non-CPE group. Independent predictors for CPE isolation were residence in a nursing home or long-term care facility, longer prior length of hospital stay (LOS), use of a urinary catheter and/or nasogastric tube, dependent functional status and exposure to carbapenem. Although in-hospital and 30 day mortality rates were similar between the two groups, LOS after CRE isolation was longer in the CPE group. Conclusions: IMP-CPE were associated with prolonged hospital stays and had different clinical and microbiological characteristics compared with non-CPE. Tailored approaches are necessary for the investigational and public health reporting, and clinical and infection prevention perspectives for IMP-CPE and non-CPE.
引用
收藏
页码:697 / 708
页数:12
相关论文
共 50 条
  • [1] Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae
    Marimuthu, Kalisvar
    Ng, Oon Tek
    Cherng, Benjamin Pei Zhi
    Fong, Raymond Kok Choon
    Pada, Surinder Kaur
    De, Partha Pratim
    Ooi, Say Tat
    Smitasin, Nares
    Thoon, Koh Cheng
    Krishnan, Prabha Unny
    Ang, Michelle Lay Teng
    Chan, Douglas Su Gin
    Kwa, Andrea Lay Hoon
    Deepak, Rama Narayana
    Chan, Yu Kit
    Chan, Yvonne Fu Zi
    Huan, Xiaowei
    Linn, Kyaw Zaw
    Tee, Nancy Wen Sim
    Tan, Thean Yen
    Koh, Tse Hsien
    Lin, Raymond Tzer Pin
    Hsu, Li Yang
    Sengupta, Sharmila
    Paterson, David L.
    Perencevich, Eli
    Harbarth, Stephan
    Teo, Jeanette
    Venkatachalam, Indumathi
    Cherng, Benjamin
    Gin, Douglas Chan Su
    Narayana, Deepak Rama
    Pratim, De Partha
    Yang, Hsu Li
    Venkatacha, Indumathi
    Hsien, Koh Tse
    Tee, Nancy
    Tek, Ng Oon
    Tat, Ooi Say
    Fong, Raymond
    Pin, Raymond Lin Tzer
    Yen, Tan Thean
    Cheng, Thoon Koh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (10)
  • [2] Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
    Tamma, Pranita D.
    Huang, Yanjie
    Opene, Belita N. A.
    Simner, Patricia J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6425 - 6429
  • [3] Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
    Tamma, Pranita D.
    Goodman, Katherine E.
    Harris, Anthony D.
    Tekle, Tsigereda
    Roberts, Ava
    Taiwo, Abimbola
    Simner, Patricia J.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) : 257 - 264
  • [4] Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae
    Miller, Shelley
    Humphries, Romney M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (08) : 705 - 717
  • [5] Carbapenemase-Producing Enterobacteriaceae
    Doi, Yohei
    Paterson, David L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) : 74 - 84
  • [6] The global epidemiology of carbapenemase-producing Enterobacteriaceae
    van Duin, David
    Doi, Yohei
    VIRULENCE, 2017, 8 (04) : 460 - 469
  • [7] Epidemiology, clinical features and outcome of bacteriemia episodes by carbapenemase-producing and non carbapenemase-producing enterobacteriaceae
    Chevel, J.
    Nievas, J.
    Torres, D.
    Rearte, A. N.
    Moreno, N.
    Bonvehi, P.
    Temporiti, E.
    Nicola, F.
    Smayevsky, J.
    Zerboni, S.
    Poletta, F.
    Herrera, F.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 289 - 289
  • [8] Detection of Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in resource-limited settings
    Kumudunie, W. G. M.
    Wijesooriya, L. I.
    Wijayasinghe, Y.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 187 - 187
  • [9] Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization*
    Jeong, Ihn Sook
    Song, Ju Yeoun
    ASIAN NURSING RESEARCH, 2022, 16 (03) : 134 - 139
  • [10] Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia
    Saidani, M.
    Hammami, S.
    Kammoun, A.
    Slim, A.
    Boutiba-Ben Boubaker, I.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 61 (12) : 1746 - 1749